iAnthus Capital Holdings Inc (IAN.CX)
0.03
0.00 (0.00%)
CAD |
CNSX |
May 03, 16:00
iAnthus Capital Holdings Debt to Equity Ratio: -2.680 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.680 |
| September 30, 2023 | -4.011 |
| June 30, 2023 | -6.261 |
| March 31, 2023 | -23.99 |
| December 31, 2022 | 13.41 |
| September 30, 2022 | 2.666 |
| June 30, 2022 | 1.959 |
| March 31, 2022 | -6.038 |
| December 31, 2021 | -8.180 |
| September 30, 2021 | 113.20 |
| June 30, 2021 | 11.96 |
| March 31, 2021 | 6.338 |
| December 31, 2020 | 3.617 |
| September 30, 2020 | 1.598 |
| June 30, 2020 | 1.318 |
| March 31, 2020 | 1.087 |
| December 31, 2019 | 0.403 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.1753 |
| June 30, 2019 | 0.1412 |
| March 31, 2019 | 0.1696 |
| December 31, 2018 | 0.2807 |
| September 30, 2018 | 0.3029 |
| June 30, 2018 | 0.3112 |
| March 31, 2018 | 0.2142 |
| December 31, 2017 | 0.6689 |
| September 30, 2017 | 0.9613 |
| June 30, 2017 | 0.8634 |
| March 31, 2017 | 0.7506 |
| December 31, 2016 | 0.042 |
| September 30, 2016 | 0.2656 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-23.99
Minimum
Mar 2023
113.20
Maximum
Sep 2021
5.616
Average
1.087
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0443 |
| Nova Mentis Life Science Corp | 0.00 |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -0.5227 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 367.87M |
| Total Liabilities (Quarterly) | 449.64M |
| Shareholders Equity (Quarterly) | -81.78M |
| Current Ratio | 0.3628 |
| Net Debt Paydown Yield | -2.07% |